Merck & Co. Inc. executive Iain Dukes told a New York audience March 4 that the company’s consolidation of business development and research capabilities into regional hubs is designed to help the pharma access innovation at the source.
The newly appointed senior vice president of Merck Research Labs’ licensing and external affairs discussed the company’s plans at New...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?